BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
3051
DELISTED
Radius Health, Inc.
RDUS
| $128K | ﹤0.01% |
6,334
-1,781
| -22% | -$43.2K |
|
3052
Clearwater Paper
CLW
$354M
| $128K | ﹤0.01% |
5,974
+3,184
| +114% | +$64K |
|
3053
Donnelley Financial Solutions
DFIN
$1.22B
| $127K | ﹤0.01% |
12,175
+6,220
| +104% | +$65.2K |
|
3054
ANI Pharmaceuticals
ANIP
$1.72B
| $127K | ﹤0.01% |
2,065
+741
| +56% | +$49.1K |
|
|
OPB
3055
DELISTED
Opus Bank Common Stock
OPB
| $127K | ﹤0.01% |
4,918
+1,678
| +52% | +$41.5K |
|
3056
Ducommun
DCO
$3.01B
| $127K | ﹤0.01% |
2,516
+819
| +48% | +$37.7K |
|
3057
BRC Group Holdings
RILY
$303M
| $127K | ﹤0.01% |
5,043
+1,739
| +53% | +$45.7K |
|
3058
Novartis
NVS
$288B
| $127K | ﹤0.01% |
1,341
-358
| -21% | -$32.1K |
|
|
UCFC
3059
DELISTED
United Community Financial Corp
UCFC
| $127K | ﹤0.01% |
10,885
+3,200
| +42% | +$35.7K |
|
|
WTRE
3060
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $127K | ﹤0.01% |
5,037
+2,135
| +74% | +$56.8K |
|
3061
National CineMedia
NCMI
$252M
| $125K | ﹤0.01% |
1,716
+408
| +31% | +$30.7K |
|
3062
First Mid Bancshares
FMBH
$1.39B
| $125K | ﹤0.01% |
3,548
+1,440
| +68% | +$50.3K |
|
3063
Codexis
CDXS
$175M
| $125K | ﹤0.01% |
7,811
-496
| -6% | -$7.34K |
|
3064
Phibro Animal Health
PAHC
$1.38B
| $125K | ﹤0.01% |
5,016
+1,333
| +36% | +$30.9K |
|
|
SOHU
3065
Sohu.com
SOHU
$364M
| $124K | ﹤0.01% |
11,126
+3,565
| +47% | +$37.3K |
|
3066
Financial Institutions
FISI
$825M
| $124K | ﹤0.01% |
3,875
+1,395
| +56% | +$44K |
|
3067
Precigen
PGEN
$2.32B
| $124K | ﹤0.01% |
22,683
-66,225
| -74% | -$373K |
|
|
RAD
3068
DELISTED
Rite Aid Corporation
RAD
| $124K | ﹤0.01% |
8,033
-100,967
| -93% | -$988K |
|
|
LDL
3069
DELISTED
Lydall, Inc.
LDL
| $124K | ﹤0.01% |
6,044
+3,335
| +123% | +$69.1K |
|
3070
CALL
Capital One
COF
$137B
| $123K | ﹤0.01% |
12
| – | – |
|
3071
Denali Therapeutics
DNLI
$3.97B
| $123K | ﹤0.01% |
7,079
-1,699
| -19% | -$28.3K |
|
|
SRDX
3072
DELISTED
Surmodics
SRDX
| $123K | ﹤0.01% |
2,973
+864
| +41% | +$36.4K |
|
3073
Forrester Research
FORR
$224M
| $123K | ﹤0.01% |
2,953
+1,021
| +53% | +$38.1K |
|
3074
Malibu Boats
MBUU
$573M
| $123K | ﹤0.01% |
3,006
-311
| -9% | -$11.2K |
|
|
TBRG
3075
DELISTED
TruBridge
TBRG
| $123K | ﹤0.01% |
4,658
+2,619
| +128% | +$65.3K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.